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Introduction
Mitochondria are key for energy metabolism within the cell, 
as they produce most of the cellular ATP through oxidative 
phosphorylation (OXP HOS) and are essential for regulating 
intermediate metabolism (Nunnari and Suomalainen, 2012). 
Changes in mitochondrial function impact not only cellular 
metabolism but also whole-body metabolism, thus affecting 
healthspan and lifespan. Nearly 300 human diseases are caused 
by mutations or defects in mitochondrial proteins, half of which 
are consequence of defects in OXP HOS, for which treatment 
options remain scarce (Koopman et al., 2012). Additionally, a 
decline in mitochondrial function is also at the basis of many 
other common disorders, including diseases that affect the met-
abolic, muscular, neurological, and immune systems (Andreux 
et al., 2013), that are often linked with aging (Houtkooper et al., 
2010; López-Otín et al., 2013, 2016). Mitochondrial function is 
also affected in cancer. However, unlike in other diseases, here 
they are not at the origin of tumorigenesis; cancer cells modify 
cellular metabolism and mitochondrial function for their own 
purposes, using them as anabolic machines (Zong et al., 2016). 
Understanding how mitochondria respond to stress and how mi-
tonuclear communication pathways adapt cellular metabolism 
to environmental changes is thus not only critical from a basic 
point of view but also has great translational value given the link 
between mitochondria and a variety of diseases.
Mitochondria are signaling organelles that continuously 
communicate with the nucleus (Chandel, 2015; Quirós et al., 
2016; Matilainen et al., 2017). This coordination is extremely 
important for energy harvesting, because OXP HOS complex 
components are encoded in both nuclear and mitochondrial 
genome, and their expression needs to be tightly regulated to 
ensure proper assembly and function (Couvillion et al., 2016). 
Although mitochondria contain an intricate and intrinsic mito-
chondrial protein quality control system, mainly mediated by 
proteases (Quirós et al., 2015), upon mitochondrial stress, mi-
tonuclear signals also instruct the nucleus to activate an adap-
tive response. Mitochondrial stress stimulates the synthesis of 
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specific mitochondrial proteins by activating mitochondrial bio-
genesis and counteracting the impact of the mitochondrial stress 
on cellular homeostasis (Yoneda et al., 2004; Houtkooper et 
al., 2013; Palikaras et al., 2015). One of the best-characterized 
retrograde stress responses is the mitochondrial unfolded pro-
tein response (UPRmt), which has been studied mainly in 
invertebrates, such as Caenorhabditis elegans and Drosophila 
melanogaster. In these organisms, mitochondrial proteotoxic 
stress activates the UPRmt, which results in the induction of the 
transcription of a set of genes encoding proteases, chaperones, 
and metabolic enzymes aimed at restoring mitochondrial func-
tion and cellular homeostasis (Yoneda et al., 2004; Durieux 
et al., 2011; Nargund et al., 2012; Houtkooper et al., 2013; 
Owusu- Ansah et al., 2013). However, in mammals, it is largely 
unknown how the UPRmt is activated, executed, and integrated 
with other general cellular stress responses.
To shed light on these mitochondrial stress pathways, we 
used a multiomics approach in mammalian cells challenged 
by four different compounds that alter mitochondrial function. 
Of note, the canonical UPRmt response that was defined in in-
vertebrates was not activated by these stressors. Instead, under 
the conditions used, they activate an integrated stress response 
(ISR) in which the activating transcription factor 4 (ATF4) is 
the main effector. ATF4 promotes the expression of particular 
cytoprotective genes that reprogram and rewire cellular me-
tabolism toward the synthesis of key metabolites, in particular 
serine. Mitochondrial stress also promotes a local proteostatic 
response by specifically decreasing mitochondrial ribosomal 
proteins (MRPs), which attenuate mitochondrial translation. In 
conclusion, our data assign a primordial role to ATF4 and the 
MRPs as main effectors of mitochondrial stress signaling and 
define a critical role of both inputs in regulating mitochondrial 
function. In addition our data provide a useful resource that can 
be exploited to identify new regulators of mitochondrial ho-
meostasis and actors in mitochondrial-related diseases.
Results
Mitochondrial stressors effectively alter 
mitochondrial function
To identify a putative common mitochondrial stress response, 
we treated cells with four drugs that alter mitochondrial proteo-
stasis in a different way: doxycycline, which inhibits mitochon-
drial translation (Moullan et al., 2015); actinonin, which alters 
the stability of OXP HOS proteins (Richter et al., 2015); the ion-
ophore carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone 
(FCCP), which disrupts mitochondrial membrane potential; and 
MitoBloCK-6 (MB), a small molecule that impairs mitochon-
drial protein import of both Mia40/Erv1 and TIM22 pathways 
(Fig. 1 A; Dabir et al., 2013). We used HeLa cells because of 
their ease of handling, high metabolic plasticity, and previous 
success to study mitochondrial function (Lanning et al., 2014; 
Münch and Harper, 2016). First, we validated our experimental 
system by characterizing different parameters of mitochondrial 
function affected by each treatment. The compounds decreased 
mitochondrial membrane potential to a different extent, with 
FCCP being the most effective (Fig. 1 B). Further, they all in-
creased mitochondrial reactive oxygen species (ROS), except 
for doxycycline, without increasing the general cellular ROS 
levels (Fig. 1, C and D). The different stressors also decreased 
both basal and maximal mitochondrial respiration (Fig.  1, 
E–G), as well as ATP-dependent respiration (Fig. 1 H). Except 
in the case of doxycycline, we also observed a decrease in the 
ratio of oxidative versus glycolytic metabolism (oxygen con-
sumption rate [OCR]/extracellular acidification rate [ECAR]); 
ECAR levels were also decreased (or showed a tendency to-
ward a decrease), suggesting that mitochondrial stress promotes 
a general decline of cellular metabolism instead of a shift to 
glycolysis to compensate for the mitochondrial defects (Fig. 1, 
I and J). Accordingly, expression of various OXP HOS subunits 
was also decreased with these compounds, with the exception 
for actinonin (Fig. 1 K). Together, these results validate our sys-
tem to map mitochondrial stress pathways that are activated by 
distinct compounds that alter mitochondrial proteostasis in dif-
ferent ways and to different degrees.
Differential changes in transcriptome and 
proteome upon mitochondrial stress
Changes in the transcriptome, proteome, and metabolome of 
HeLa cells treated for 24 h with the four different compounds 
(doxycycline, actinonin, FCCP, and MB) were determined by 
RNA sequencing, quantitative proteomic analysis using tandem 
mass tag (TMT) technology, and nontargeted metabolomics 
analysis (Fig. 2 A). We initially focused on changes in tran-
scripts and proteins, and we identified 15,174 unique transcripts 
and 8,067 unique proteins in all conditions, of which 1,053 
transcripts and 878 proteins were mitochondrial, based on 
MitoCarta2.0 (Calvo et al., 2016), representing 6.9% and 10.8% 
of the transcriptome and proteome, respectively (Fig. 2 B and 
Tables S3 and S4). Hierarchical clustering and heatmap analy-
sis of the duplicate samples indicated the reproducible nature 
of our analysis, as exemplified by the similarity between repli-
cates, but also highlighted differential expression changes be-
tween the treatments (Fig. 2 C). Multidimensional scaling and 
principal-component analysis also confirmed a good accordance 
between biological duplicates, as well as the close clustering of 
transcripts and proteins upon different treatments (Fig. 2 D). In 
fact, these clustering methods suggested that doxycycline in-
duces a similar but less pronounced response as compared with 
actinonin and FCCP, whereas MB displayed a completely dif-
ferent transcriptional and proteomic response (Fig. 2, C and D). 
Using a significance level of false discovery rate (FDR) <0.05, 
we identified the differentially expressed genes and proteins 
upon each stress (Fig. 2 E; and Fig. S1, A and B). For each com-
pound, the observed response was different, showing in some 
conditions more changes at the transcript level, as for actino-
nin and MB, whereas upon doxycycline and FCCP treatment, 
the protein changes were more pronounced (Fig. 2 E and Fig. 
S1, A and B). Importantly, in all conditions, changes affecting 
mitochondria were much higher in the proteome than in the 
transcriptome, with the percentage of differentially expressed 
mitochondrial proteins being approximately three times higher 
than differential genes (Figs. 2 E and S1 C).
Next, we compared the changes in the levels of 7,885 
transcripts and proteins that were commonly detected in each 
analysis (Fig. S1 D). Also for the common genes, changes in the 
proteome were also more pronounced than those observed in the 
transcriptome, and only a limited overlap between the changes in 
transcripts and proteins was detected, demonstrating that stress 
response differentially affects the transcriptome and proteome 
(Fig. S1 E). Nevertheless, we observed a positive and highly sig-
nificant correlation between the transcriptomic and proteomic 
changes in all conditions (Fig. S1 F). However, despite the ex-
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treme significance owing to the high number of observations, it is 
evident that the higher correlations (rho of ∼0.4) were associated 
with compounds that induced major changes, such as actinonin 
and FCCP (Fig. S1 F). This is in agreement with the fact that 
each stress generates a different response and that mRNA and 
protein levels are not perfectly correlated (Chick et al., 2016; Wil-
liams et al., 2016). Altogether, these results demonstrate that mi-
tochondrial stress differentially alters the cellular transcriptome 
and proteome, with the changes at the protein level in mitochon-
dria being more pronounced.
Mitochondrial stress decreases MRPs, 
inhibits mitochondrial translation, and 
alters epigenetic regulators
We next explored the down-regulated transcripts and proteins 
that were common to all stress conditions. Using a FDR of 5%, 
we identified only four genes down-regulated in RNA sequenc-
ing, whereas 101 proteins were identified by proteomic analysis 
(Fig. 3 A and Table S5). These differences are in agreement with 
the global changes in the transcriptome and proteome described 
above (Fig. 2 E). Notably, among the 101 down-regulated pro-
teins, 44 were mitochondrial (Table S5). Enrichment analysis 
of these down-regulated proteins identified “Ribosome” as the 
top down-regulated pathway, as well as “Oxidative phosphory-
lation” and “Mitochondrial translation” (Figs. 3 B and S2 A). 
Network analysis of down-regulated proteins pointed out the 
specific enrichment in MRPs, proteins related to mitochondrial 
translation, and OXP HOS subunits (Fig.  3  C). Interestingly, 
the decrease in MRPs was only observed in the proteome; no 
changes were observed at the transcript level (less than onefold 
change; Figs. 3 D and S2 B). OXP HOS proteins were also de-
creased at the protein level, except for actinonin, where an in-
crease in these proteins was observed (Figs. 3 E and S2 C). This 
result demonstrates that actinonin causes an accumulation of 
nonfunctional OXP HOS proteins, because mitochondrial respi-
ration was decreased (Fig. 1, E and F), validating the proposed 
mechanism of action of actinonin, which was reported to impair 
the turnover of de novo mitochondrial protein synthesis (Rich-
ter et al., 2015). Similarly to MRPs, mitochondrial stress did 
not change OXP HOS transcripts (Figs. 3 E and S2 C). Notably, 
Figure 1. Mitochondrial stress alters mitochondrial function. (A) Schematic representation of the mechanism of action of the compounds selected for the 
analysis. Acti, actinonin; Dox, doxycycline; MB, MitoBloCK-6. (B) Mitochondrial membrane potential after 24 h of treatment with the selected chemicals. 
Tetramethylrhodamine, methyl ester (TMRM) was used to determine mitochondrial membrane potential (n = 4 independent experiments; mean values ± SEM). 
(C) Mitochondrial and (D) total ROS levels after 24 h of treatment with the selected chemicals. Dichlorofluorescin diacetate (DCF-DA) reflects total cellular 
ROS levels, whereas MitoSox measure mitochondrial superoxide level. RFU, relative fluorescence units (n = 4 independent experiments; mean values ± SEM). 
(E) Oxygen consumption rate (OCR) of cells treated with the different compounds. Dashed vertical lines indicate the subsequent addition of the ATPase inhib-
itor oligomycin (Olig.), the uncoupling reagent FCCP and the inhibitors of the electron transport chain rotenone/antimycin A (Rot/Ant). (F and G) Boxplots 
representing OCR (F) in basal conditions and (G) after treatment with the uncoupler FCCP (maximal respiration). (H) Boxplot representing the ATP-dependent 
respiration (oligomycin-sensitive respiration) calculated as the difference in OCR before and after the addition of oligomycin. (I) Ratio of OCR and extracellular 
acidification rate (ECAR) as an indicator of the relation between mitochondrial respiration and glycolysis. (J) ECAR in basal conditions as indication of gly-
colytic rate. For E–J, n = 2 independent experiments, using 10 replicates per experiment; mean values ± SEM of a representative experiment. (K) Inmunoblot 
analysis showing the effects of the compounds on different mitochondrial OXP HOS subunits (ATPA5, complex V; UCQ RC2, complex III; MTCO1, complex IV; 
SDHB, complex II; and NDU FB8, complex I). HSP90 was used as loading control. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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individual analysis of each stressor also evidenced changes in 
mitochondrial translation and OXP HOS as the main enriched 
pathways (Tables S6 and S7).
Of note, mitochondrial stress also decreased the protein 
levels of OPA1 (Table S5), a mitochondrial inner membrane 
GTPase that participates in the inner membrane fusion and 
cristae maintenance (Frezza et al., 2006; Cogliati et al., 2013). 
Upon different mitochondrial insults, long OPA1 isoforms are 
proteolytically processed by the stress-dependent mitochondrial 
protease OMA1, inhibiting mitochondrial fusion and promoting 
mitochondrial fragmentation (Quirós et al., 2012; Baker et al., 
2014). However, despite the decrease in total protein levels, 
only actinonin and FCCP triggered the processing of the long 
OPA1 isoforms (Figs. 3 F and S2 D; showing different times).
Besides mitochondrial proteins, some epigenetic regula-
tors were also down-regulated upon mitochondrial stress. These 
include the histone methyl transferases SETD2, SUV39H1, 
and ATF7IP, as well as components of some histone acetyl-
transferase complexes, such as MORF4L1, ZZZ3, and MRG 
BP (Table S5). These data confirm recent findings that mito-
chondrial activity is required for histone acetylation (Martínez-
Reyes et al., 2016) and that mitochondrial stress activates 
different histone methyl transferases and demethylases to regu-
late stress adaptation (Schroeder et al., 2013; Merkwirth et al., 
2016; Tian et al., 2016).
Mitochondrial stress activates metabolic 
pathways of amino acid biosynthesis
Next, we analyzed the common up-regulated genes and pro-
teins in mitochondrial stress conditions. Unlike down-regulated 
changes, here we found that the major increase was observed 
at the transcript level, with 59 genes and only 17 proteins com-
monly up-regulated (Fig.  4  A and Table S5). Notably, among 
those changes, only four genes and two proteins were mito-
chondrial (Table S5), illustrating that the main response upon 
mitochondrial stress does not involve the induction of mitochon-
drial genes. Enrichment analysis of both RNA sequencing and 
proteomic analysis identified pathways related to biosynthesis 
of amino acids (Fig.  4  B), in particular biosynthesis of serine 
(Figs. 4 B and S3 A). Specifically, pathways of “Biosynthesis 
Figure 2. RNA sequencing and proteomic analysis upon mitochondrial stress. (A) Schematic representation of the omics experiments. HeLa cells were 
treated with compounds for 24 h, and the transcriptome, proteome, and metabolome were analyzed. Control cells were treated with DMSO. (B) Pie charts 
representing the total number of genes and proteins identified in all conditions by RNA sequencing and TMT quantitative proteomic analysis. Number of 
mitochondrial genes and proteins are represented in both charts, as well as the percentage relative to the total. (C) Heatmap analysis of the transcriptome 
(top) and proteome (bottom). Hierarchical clustering of samples (columns) and genes/proteins (rows) was based on Pearson’s correlation coefficient to mea-
sure the distance and the mean to cluster the samples. (D) Multidimensional scaling (MDS) using the distances between transcript expression profiles (top) 
and principal-component analysis (PCA) of the proteomic profiles (bottom) show a similar clustering between the duplicates and treatments. BCV, biological 
coefficient of variation; Comp, principal component. (E) Bar plots representing the number of differentially expressed (DE) genes (top) and proteins (bottom) 
in each condition (FDR 5%). Percentage of DE mitochondrial genes and proteins is shown, observing a greater impact on the mitochondrial proteome than 
on the mitochondrial transcriptome. Acti, actinonin; Dox, doxycycline; MB, MitoBloCK-6.
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of amino acids,” “Glycine, serine and threonine metabolism,” 
“Carbon metabolism,” “Vitamin B6 metabolism,” and “mTOR 
signaling pathway” were enriched in both transcriptome and pro-
teome (Fig. 4 B). Analysis of individual genes and proteins also 
showed the up-regulation of the key enzymes of serine biosynthe-
sis (PSAT1, PSPH, and PHG DH), as well as serine dehydratase, 
SDSL (Fig. 4 C and Table S5). These changes suggest that ser-
ine is generated de novo from 3-phosphoglycerate and converted 
into pyruvate, also replenishing intermediates of the tricarboxylic 
acid cycle, such as α-ketoglutarate (Fig.  4  C). In addition, we 
observed an induction of the mitochondrial enzyme phosphoe-
nolpyruvate carboxykinase 2 (PCK2), which allows the cells to 
use alternative cataplerotic pathways to convert tricarboxylic acid 
cycle intermediates into glycolytic intermediates (Fig. 4 C and 
Table S5). Furthermore, the up-regulation of some enzymes of 
the one-carbon metabolism (ALDH1L2), cysteine biosynthesis 
(CTH), and glutathione (GSH) cycle (CHAC1) also suggested an 
increase in the flux toward the transsulfuration pathway to syn-
thesize GSH, supported by the methionine cycle (Fig. 4 C and 
Table S5). In addition, several amino acid transporters (SLC1A4, 
SLC1A5, SLC6A9, and SLC7A11), as well as key enzymes for 
the synthesis of asparagine (ASNS) and arginine (ASS1), were 
also induced (Table S5).
Moreover, “Aminoacyl−tRNA biosynthesis” was also 
enriched in RNA sequencing results (Fig.  4  B). However, 
only cytosolic amino acid–tRNA synthetases (aaRSs) were 
consistently induced at both the mRNA and protein level; 
mitochondrial aaRSs showed variable regulation depend-
ing of each stressor (Fig. 4 D). Gene set enrichment analysis 
(GSEA) of the transcriptomes of all stressors evidenced simi-
larity in gene expression changes with those seen after amino 
acid deprivation (Krige et al., 2008) and with several cancer 
studies (Figs. 4 E and S3 B). Notably, despite the differential 
changes induced by each stressor, individual enrichment anal-
ysis of transcripts modulated by each compound also showed 
the activation of those metabolic pathways as the main stress 
responses (Tables S6 and S7).
We also observed the up-regulation of two proteins as-
sociated with the ubiquitin-proteasome system, UBA5 and 
UHRF1BP1 (Table S5), which might suggest an increase in 
protein degradation. In fact, in other species like yeast, mito-
chondrial stress can trigger the activation of the proteasome 
to degrade mitochondrial proteins accumulated in the cytosol 
(Wrobel et al., 2015). However, proteasome activity was de-
creased in all stress conditions, with the exception of doxycy-
cline (Fig. S3 C), which can be explained by the increase in 
Figure 3. Mitochondrial stress inhibits mitochondrial translation and decreases mitochondrial ribosomal proteins and OXP HOS complexes. (A) Venn dia-
grams showing commonly down-regulated genes (top) and proteins (bottom) with an FDR < 0.05. (B) Enrichment analysis of 101 proteins down-regulated 
was performed using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and represented as negative of log10 of p-value after Bonferroni 
correction. (C) A STR ING network showing the enrichment in mitochondrial ribosomal proteins (MRPs; yellow) and OXP HOS proteins (blue). Line thickness 
indicates the strength of the association. (D and E) Correlation of transcript and protein data for the (D) MRPs and (E) OXP HOS components with each 
stressor. Values are represented as log2-fold changes (FC) relative to control. Dashes lines depict the 0 values to indicate the up- or down-regulation in each 
analysis. (F) Western blot analysis of OPA1 upon treatment for 24 h with each stressor. Long OPA1 isoforms (L-OPA1) and short OPA1 isoforms (S-OPA1) 
are indicated. Acti, actinonin; Dox, doxycycline; MB, MitoBloCK-6; NAF LD, non-alcoholic fatty liver disease.
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mitochondrial ROS (Fig. 1 C), which is known to inhibit prote-
asome activity (Segref et al., 2014).
Mitochondrial stress alters cellular 
metabolism
To study the metabolic footprint of mitochondrial stress, we 
analyzed the changes in the metabolome induced by exposure 
to mitochondrial stressors. Approximately 300 detectable peaks 
were putatively annotated as deprotonated metabolites by ac-
curate mass and used to explore the differences between con-
ditions. Both hierarchical clustering with heatmap analysis and 
multidimensional scaling segregated the samples by compound, 
tightly grouping the replicates (Figs. 5 A and S3 D). These re-
sults were similar to those observed in the transcriptome and 
proteome analysis (Fig. 2, C and D); however, in this case, the 
moderate impact of doxycycline was even more evident (Figs. 
5 A and S3 D). Analysis of differentially expressed metabolites 
and pathway enrichment analysis with the unique metabolites 
showed that pathways of glycerophospholipid and sphingolipid 
metabolism were the most highly induced upon mitochondrial 
stress (Fig. 5 B). These pathways were also indicated by an-
alyzing the top up-regulated and down-regulated metabolites 
in common between the stressors, where we found increased 
levels of ceramide, CDP-ethanolamine, and several species of 
lysophosphatidycholine and lysophosphatidylethanolamine 
(Fig.  5  D). These changes reveal that the increase in serine 
might be used to promote the synthesis of lipids and phospho-
lipids through ceramide, which has a key role during mitochon-
drial stress in C. elegans (Liu et al., 2014; Kim et al., 2016). Of 
note, we also found several metabolites related to cholesterol 
and prostaglandin metabolism to be up-regulated (Fig. 5 D), in 
line with previous studies (Rauthan et al., 2013; Andreux et al., 
2014; Liu et al., 2014). Importantly, these findings suggest a 
high degree of conservation in the link between mitochondrial 
stress and lipid metabolism across different organisms.
On the other hand, analysis of the top down-regulated 
pathways showed alterations in several amino acid–related 
pathways, such as taurine and hypotaurine, cysteine and me-
thionine, and GSH metabolism, among others (Fig. 5 C). No-
tably, many amino acids and derivatives were also significantly 
altered, but our resolution could not completely distinguish 
them from other metabolites, although in general an increase 
Figure 4. Mitochondrial stress increases biosynthesis of amino acids. (A) Venn diagrams showing commonly up-regulated transcripts (top) and proteins 
(bottom) with an FDR < 0.05. (B) Enrichment analysis of 59 transcripts (top) and 17 proteins (bottom) up-regulated were performed using KEGG pathways 
and are represented as negative of log10 of p-value after Bonferroni correction. Common enriched pathways in RNA sequencing and proteomics are 
represented in bold. (C) Graphical representation of enzymes and metabolites of de novo serine biosynthesis and their integration in cellular metabolism. 
Enzymes highlighted in red are up-regulated in RNA sequencing and in red bold in both RNA sequencing and proteomics. (D) Correlation of cytosolic 
and mitochondrial amino acid-tRNA synthetase (aaRS) genes and proteins in each stress condition. Values are represented as log2-fold changes (FC) 
relative to control. Dashes lines depict the 0 values to indicate the up- or down-regulation in each analysis. (E) Enrichment score plots from GSEA using a 
combine mitochondrial stress expression extracted from the RNA seq. 3PG, 3-phosphoglycerate; Acti, actinonin; Dox, doxycycline; FDR, false discovery 
rate; Glc, glucose; MB, MitoBloCK-6; NES, normalized enrichment score; PEP, phosphoenolpyruvate; PHG DH, phosphoglycerate dehydrogenase; PSAT1, 
phosphoserine aminotransferase 1; PSPH, phosphoserine phosphatase; Pyr, pyruvate; SDSL, serine dehydratase; Ser, serine; TCA, tricarboxylic acid.
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in almost all amino acids was observed (Table S8). Analysis 
of individual metabolites confirmed the up-regulation of serine, 
asparagine, and arginine (Fig. 5 D), consistent with the increase 
in their biosynthetic enzymes (Fig. 4 C and Table S5). The in-
crease in serine, which was one of the most highly induced me-
tabolites, was also indicated by the increase in the ratio serine/
phosphoserine, providing further support for the up-regulation 
of the activity of the serine biosynthetic pathway (Fig. 5, D and 
E). Conversely, one of the metabolites most decreased in all 
conditions was aspartic acid (Fig. 5 D), a finding that is con-
sistent with the up-regulation of ASNS and the consequent in-
crease in asparagine (Fig. 5 D and Table S5).
Moreover, one of the most up-regulated metabolites was 
γ-glutamylcysteine (Fig. 5 D), which is a precursor of GSH 
(Fig. 5 F). However, GSH levels were decreased (Fig. 5, D and 
F), suggesting a decrease in its synthesis, an increase in its deg-
radation, or an increase in the oxidized forms (Fig.  5  F). To 
assess the origin of this reduction in GSH, we ascertained the 
levels of the different enzymes and metabolites implicated in its 
cycle. Oxidized glutathione (GSSG) showed differential levels 
depending on the stressor; however, the GSH/GSSG ratio was 
decreased with almost all stressors (Fig. 5 G), indicating that 
the oxidative damage may explain the GSH depletion. Further, 
almost all the enzymes of the GSH cycle were increased at the 
protein level, and gamma-glutamylcyclotransferase CHAC1 
was extremely up-regulated (Fig. S3 E), suggesting an increase 
in GSH cycle metabolism. Intriguingly, we observed an increase 
in the levels of cysteine-GSH disulfide (Fig. 5, D and F) and a 
decrease in the GSH/cysteine-GSH disulfide ratio (Fig. 5 H), 
which further explains the decline in GSH levels.
Besides amino acid related metabolism, other important 
metabolites were also changed, reflective of global metabolic 
Figure 5. Metabolomic analysis of mitochondrial stress. (A) Multidimensional scaling (MDS) using the unique metabolites identified. Metabolome pathway 
enrichment of (B) up-regulated and (C) down-regulated metabolites upon mitochondrial stress. Scatterplots represents p-values from integrated enrichment 
analysis and impact values from pathway topology analysis. The node color is based on the p-values and the node radius represents the pathway impact 
values. (D) Dot plot representing the fold change of the top changed metabolites in each mitochondrial stress condition. Fold change is represented in log 
scale and all metabolites show significant differences with an FDR <0.05. (E) Box-whisker plots representing the ratio of serine and phosphoserine levels 
in each mitochondrial stress condition. (F) Graphical representation of enzymes and metabolites of the glutathione (GSH) cycle. Enzymes and metabolites 
highlighted in red are up-regulated upon mitochondrial stress, whereas those in blue are down-regulated. (G and H) Box-whisker plots representing the 
levels of (G) oxidized glutathione (GSSG) and the ratios of GSH to GSSG (GSH/GSSG) and (H) GSH to cysteine glutathione disulfide (GSH/CYS SG). **, 
P < 0.01; ***, P < 0.001. Acti, actinonin; CE, cholesterol ester; DG, diacylglycerol; Dox, doxycycline; MB, MitoBloCK-6; MG, monoacylglycerol; PC, 
phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PS, phosphatidylserine.
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changes induced upon mitochondrial stress. We found increased 
levels of phosphoenolpyruvic acid, which was consistent with 
the up-regulation of PCK2 and the activation of the cataplerotic 
reaction from OAA (Figs. 4 C and 5 D). On the other hand, the 
decrease in orotidylic acid (Fig. 5 D), which is implicated in 
the synthesis of uridine, was remarkable and likely attributed to 
the decreased activity of dihydroorotate dehydrogenase, which 
requires the electron transport chain for its normal function 
(Grégoire et al., 1984). Further, acetyl coenzyme A was also 
down-regulated (Fig.  5  D), agreeing with the starvation-like 
status and the decrease in mitochondrial function (Mariño 
et al., 2014; Martínez-Reyes et al., 2016). Altogether, these 
changes demonstrate that upon mitochondrial dysfunction, a 
compensatory response is triggered, aimed at synthesizing key 
metabolites, which maintain cellular metabolism, promote the 
synthesis of certain lipids, and regulate the pool of GSH.
ATF4 coordinates the mitochondrial 
stress response
To identify the putative factors that control this transcriptional 
stress response, we performed a de novo motif analysis in 
the common up-regulated genes using HOM ER (Heinz et al., 
2010). Among all possible motifs, the top-scoring motif, and 
the only one that was not assigned as a possible false positive, 
was 5′-TTG CAT GACG-3′, which was found in 17.65% of the 
target genes (Fig.  6 A). This target sequence was similar to 
the motif bound by bZIP-containing proteins, such as ATF4, 
DDIT3/CHOP, and CEB PB, with ATF4 being the most likely 
and highest scoring transcription factor associated with this 
sequence (Fig. 6 B). We indeed confirmed the likely involve-
ment of ATF4 by comparing the chromatin immunoprecipita-
tion and sequence data available for this factor, as well as for 
CHOP (Han et al., 2013), with the changes in transcript level 
observed in our RNA sequencing data. Remarkably, approx-
imately half of the genes (26/59) that were induced in com-
mon by the different mitochondrial stressors were also ATF4 
targets (Fig. 6 C). This overlap was also evident when com-
paring up-regulated proteins (Fig. 6 D). Of note, some of the 
up-regulated genes (13/59) also were potential CHOP targets; 
however, because all those genes were also ATF4 targets and 
CHOP only overlapped with half of them, we hypothesized 
that CHOP activation is a downstream event in this context 
(Fig. S4 A). Accordingly, ATF4 transcript and protein levels 
were induced upon mitochondrial stress (Fig. 6 E), being acti-
vated also at early time points (Fig. 6 F).
To further consolidate the role of ATF4 in mitochondrial 
stress response, we generated HeLa cells deficient in ATF4 
using CRI SPR-Cas9 technology (Fig. S4 B). ATF4 loss of 
function (LOF) was confirmed by treating these cells with the 
mitochondrial stressor actinonin and the ER stressor tunicamy-
cin (Fig. S4 C), which also induces ATF4 during the unfolded 
protein response in the ER (UPRer; Hetz, 2012). ATF4 LOF ab-
rogated the mitochondrial stress response, illustrated by the de-
creased levels of several of its targets, including ASNS, CHAC1, 
PCK2, and PSHP (Fig. 6 G). Treatment with tunicamycin also 
activated the same ATF4-dependent response, which indeed 
was suppressed in the ATF4-deficient cells (Fig.  6  G). Mito-
chondrial stress did not, however, activate the expression of the 
ER chaperone BIP (also known as HSP5A or GRP78), a clas-
sical UPRer marker, and therefore, ATF4 LOF did not abolish 
the tunicamycin-mediated BIP induction (Fig. 6 G). Similarly, 
other UPRer branches, including those governed by the ATF6 
or IRE1/XBP1 pathways, were not activated upon mitochon-
drial stress (Fig. S4 D).
ATF4 LOF increased ATP-dependent respiration (Fig. 6 H), 
suggesting a role in regulating mitochondrial function; however, 
it also promoted a decrease in cellular proliferation, exempli-
fied by an increase in cellular doubling time (Fig. 6 I). We then 
explored the role of ATF4 during the recovery from mitochon-
drial stress induced by mitochondrial DNA (mtDNA) depletion. 
WT and ATF4 LOF HeLa cells were treated with ethidium bro-
mide (EtBr) for 6 d, showing a comparable depletion in mtDNA 
(Fig. 6 J). After EtBr removal, both cell types recovered mtDNA 
levels at similar rates (Fig. 6 J), indicating that ATF4 is not in-
volved in mtDNA metabolism. Strikingly, ATF4 LOF cells pro-
liferated significantly less than control cells, with and without 
EtBr treatment; this decrease in proliferation was even more 
enhanced upon recovery from mtDNA depletion (Fig. 6 K), in-
dicating that ATF4 is essential to maintain cell proliferation and 
to protect against mitochondrial stress.
ATF4 is activated through the ISR
ATF4 is one of the prototypical transcription factors activated 
during the ISR. The ISR is activated by different cellular stressors 
and culminates in the phosphorylation of the translation initiation 
factor eIF2α, which reduces total protein synthesis while allowing 
preferential translation of some transcription factors that have up-
stream ORFs in their 5′ UTRs, like ATF4 and ATF5 (Ron, 2002; 
Pakos-Zebrucka et al., 2016). eIF2α can be phosphorylated by four 
kinases, each of which is activated by different forms of cellular 
stress: PERK (ER stress), GCN2 (amino acid starvation), PKR 
(double-stranded RNA), and HRI (reduced heme levels; Balachan-
dran et al., 2000; Harding et al., 2000, 2003; Han et al., 2001). 
Although ATF4 acts as a common downstream target that inte-
grates signals from those eIF2α kinases, it has also been reported 
to be activated by an independent mechanism upon mitochondrial 
stress (Münch and Harper, 2016) or even in an mTOR-dependent 
way (Ben-Sahra et al., 2016). All mitochondrial stressors that we 
used stimulated the phosphorylation of eIF2α (Fig. 7 A). Further-
more, treatment with ISR IB, an ISR inhibitor that blocks eIF2α 
phosphorylation (Sidrauski et al., 2015), reduced the induction of 
ATF4 and several of its target genes (Fig. 7, B and C). As observed 
upon ATF4 LOF (Fig. 6 G), ISR IB treatment also abolished the 
activation of the ATF4 pathway mediated by tunicamycin (Fig. 7, 
B and C) but did not suppress the activation of BIP (Fig. 7 C). Fur-
ther, ISR IB also increased basal and ATP-dependent respiration 
(Fig. 7, D), supporting that the activation of the ISR and the atten-
uation in cytosolic translation also affect mitochondrial function 
in nonstress conditions.
Finally, to identify which kinase acts upstream of the 
ISR activation upon mitochondrial stress, we knocked down 
the four known eIF2α kinases individually in HeLa cells using 
shRNAs (Fig. 7 E) and thereafter treated the cells with FCCP, 
which activates the ATF4 pathway most robustly. Individual 
knockdown of the kinases, however, did not abolish the in-
duction of ATF4 and its target genes (Fig. 7 F). These results 
demonstrate that mitochondrial stress activates the ATF4 path-
way through the ISR but independently of the activation of an 
individual eIF2α kinase.
Mitochondrial stress activates the ATF4 
pathway in vitro and in vivo
It has been previously reported that alterations in mitochondrial 
proteostasis activate the UPRmt (Yoneda et al., 2004; Durieux et 
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al., 2011; Houtkooper et al., 2013; Münch and Harper, 2016). 
However, in our study, we did not detect consistently the activa-
tion of the prototypical UPRmt, as reflected by HSPD1, HSPE1, 
or CLPP expression (Fig. S4 E). To unravel if these differences 
were based on the type of stress, we tried to reproduce the orig-
inal conditions used to trigger the UPRmt in mammalian cells 
by transfecting a mutant form of ornithine transcarbamylase 
(ΔOTC), which was reported to induce protein misfolding in 
mitochondria (Zhao et al., 2002). However, we could not detect 
the activation of the UPRmt, as previously reported (Fig. S4 F; 
Zhao et al., 2002). Next, we used paraquat, an inhibitor of mi-
tochondrial complex I that increases mitochondrial ROS levels, 
which has been also described as potent UPRmt inducer through 
the activation of ATF5 (Fiorese et al., 2016). However, paraquat 
treatment consistently activated the ATF4 pathway, having no 
effect on ATF5 and the UPRmt genes (Fig. 8 A). Inhibition of 
the mitochondrial chaperone TRAP1 by GTPP or of the Lon 
protease (LONP1) by CDDO has also been reported to activate 
the UPRmt, as well as the ATF4 pathway in vitro (Münch and 
Harper, 2016). We then compared the transcripts induced by 
both inhibitors with the changes observed in our stress condi-
tions by performing a GSEA using the core set of genes com-
monly up-regulated with our four stressors, hereafter referred 
as mt-stress genes (Table S5). Expression of mt-stress genes 
was significantly enriched in HeLa cells treated with GTPP and 
CDDO (Münch and Harper, 2016; Fig. 8, B and C), indicating 
that inhibition of TRAP1 and LONP1 also activated a similar 
stress response pathway mediated by ATF4. Likewise, knock-
Figure 6. ATF4 mediates the mitochondrial stress response. (A) Consensus de novo motif identified using HOM ER software by selecting the common 
up-regulated genes in all stress conditions. (B) Representation of the common transcription factors that match with the identified motif. (C and D) Venn 
diagram showing the similarity between the ATF4 targets and the common induced (C) transcripts and (D) proteins reflecting mitochondrial stress in RNA 
sequencing and proteomics analysis, respectively. ATF4 chromatin immunoprecipitation and sequence: GSE35681. (E) Relative mRNA, represented as 
normalized counts, and relative protein levels of ATF4. Data were extracted from RNA sequencing and proteomics, respectively. †, P < 0.1; **, P < 0.01; 
***, P < 0.001. (F) Transcript levels of ATF4, CHOP (DDIT3), and ASNS upon 6 and 24 h of exposure to the different mitochondrial stressors. Expression 
of ATF4 and its targets genes showed time-dependence activation. **, P < 0.01; ***, P < 0.001 relative to control at 6 h; $, P < 0.001 relative to control 
at 24 h. (G) mRNA expression analysis of ATF4 targets, ASNS, CHAC1, PCK2, PSPH, and the ER stress marker BIP upon 6 h of treatment with the different 
mitochondrial stressors and the ER stressor tunicamycin (Tn at 2.5 µg/ml) in WT and ATF4 LOF HeLa cells. (H) Boxplots showing the basal and ATP- 
dependent respiration of ATF4 LOF HeLa cells. OCR, oxygen consumption rate. (I) Doubling time in hours of WT and ATF4 LOF HeLa cells. (J) Relative 
mtDNA levels of WT and ATF4 LOF HeLa cells after 6 d of 50 ng/ml EtBr treatment and 4 d of recovery (10 d). (K) Cumulative cell number of WT and 
ATF4 LOF HeLa cells treated or untreated with EtBr for 10 d (6 d with EtBr and 4 d of recovery). All experiments were independently performed at least two 
times, using triplicates for each condition; data are presented as mean ± SEM of a representative experiment, *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
Acti, actinonin; Dox, doxycycline; MB, MitoBloCK-6.
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down of LONP1 expression, which promotes the accumulation 
of misfolded proteins and induces a robust mitochondrial pro-
teotoxic stress (Bernstein et al., 2012; Quirós et al., 2014), also 
activated the ATF4 pathway but did not consistently activate 
the classical UPRmt markers (Fig. 8 D). Importantly, the ATF4 
pathway was also induced by the same mitochondrial stressors 
in mouse embryonic fibroblasts (MEFs; Fig. S4 G), demonstrat-
ing that this stress response is not restricted to a specific cellu-
lar model. In combination, these results suggest that under the 
conditions tested, mitochondrial stress in mammalian cells does 
not activate the classical prototypical UPRmt, defined in worms 
(Yoneda et al., 2004; Haynes et al., 2007; Durieux et al., 2011; 
Houtkooper et al., 2013) or in mammals (Martinus et al., 1996; 
Zhao et al., 2002; Münch and Harper, 2016), but rather induces 
the ATF4 pathway via the activation of the ISR.
We next studied the relationship between ATF4 activation 
and other mitochondrial stress responses, such as the regula-
tion of mitochondrial dynamics. As we previously described, 
stressors that promote OPA1 processing and mitochondrial 
fragmentation, like FCCP and actinonin (Figs. 3 F and S2 D) 
or knockdown of LONP1 (Quirós et al., 2014), also activated 
the ATF4 pathway. However, because OPA1 was not processed 
in all stress conditions analyzed (Figs. 3 F and S2 D), the tran-
scriptional stress response mediated by ATF4 and mitochon-
drial fragmentation are probably two noninterdependent stress 
pathways. Further, treatment with mdivi-1, an inhibitor of the 
dynamin GTPase DRP1 that blocks mitochondrial division 
(Cassidy-Stone et al., 2008), also activated the ATF4 pathway 
in a time-dependent way (Fig. 8 E), demonstrating that different 
mitochondrial stress conditions can activate the ATF4 pathway 
independent of mitochondrial fragmentation. Notably, mdivi-1 
treatment also did not consistently activate the UPRmt (Fig. 8 E).
Finally, we explored whether the activation of mt-stress 
genes can also arise in mitochondrial dysfunction in vivo or in 
human mitochondrial diseases. For this, we analyzed the expres-
sion of the mt-stress genes in tissues derived from mice deficient 
in the mitochondrial quality control proteases Clpp (Gispert et 
al., 2013) and HtrA2 (Moisoi et al., 2009). Deficiency in both 
mitochondrial proteases, which trigger mitochondrial proteo-
toxic stress and promote severe physiological alterations, acti-
vated the same ATF4 response in heart and brain, respectively, 
as illustrated in the enrichment plots obtained from GSEA 
(Fig. 8, F and G). Importantly, we also found that expression of 
the mt-stress genes was significantly correlated with gene ex-
Figure 7. ATF4 is activated through the ISR. (A) Western blot analysis showing the increased phosphorylation of eIF2α (Ser51) upon 6 h of treatment with 
the different mitochondrial stressors. Bottom, ratio between P-eIF2α and eIF2α total levels. (B and C) mRNA expression analysis of ATF4 and its target genes, 
CHOP (DDIT3), ASNS, CHAC1, PCK2, and the ER stress marker BIP, upon 6 h of treatment with the different mitochondrial stressors and the ER stressor tuni-
camycin (Tn at 2.5 µg/ml) in HeLa cells, together with the inhibitor of the integrated stress response (ISR IB at 500 nM). (D) Boxplots showing an increase in 
basal and ATP-dependent respiration of HeLa cells treated with 500 nM of ISR IB for 24 h. OCR: oxygen consumption rate. (E) mRNA expression analysis of 
eIF2α kinases upon knock down with specific shRNAs. Data are presented as mean ± SEM of two independent shRNAs for each gene. Statistical differences 
were calculated compared with pLKO1. (F) mRNA expression analysis of ATF4 and some of its target genes upon knock down of the eIF2α kinases and 
6 h of treatment with FCCP. Data are presented as mean ± SEM of two independent shRNAs for each gene. No statistical differences were found between 
the FCCP treated conditions. All experiments were independently performed at least two times, using triplicates for each condition; data are presented as 
mean ± SEM of a representative experiment; *, P < 0.05; **, P < 0.01; ***, P < 0.001. Acti, actinonin; Dox, doxycycline; MB, MitoBloCK-6.
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pression changes observed in human mitochondrial myopathies 
(Fig. 8 H), especially in those with mtDNA deletions (Fig. 8 I). 
Collectively, these data demonstrate that mitochondrial stress 
activates the ATF4 pathway both in vitro and in vivo and is also 
implicated in human disease with a mitochondrial origin.
Genetic link between ATF4 pathway and 
mitochondrial stress in human and  
mouse populations
To further explore the link between the activation of the ATF4 
pathway and mitochondrial function, we analyzed the expres-
sion of mt-stress genes in the GTEx data (GTEx Consortium, 
2013) and the BXD mouse genetic reference population (An-
dreux et al., 2012). Network analysis using multiple tissue 
correlations showed a tight clustering of the mt-stress genes, 
supporting the idea of a common in vivo coregulation across 
49 human tissues (Fig. 9 A) and 16 mouse tissues (Fig. 9 B) in 
a nonstressed basal situation. Next, we correlated the expres-
sion of different transcription factors, including ATF4, DDIT3/
CHOP, and CEB PB, with all the other genes in the 49 human 
tissues from GTEx data, which show a tighter clustering for 
the mt-stress genes compared with the BXD data. Enrichment 
analysis of the top negative-correlated genes identified several 
metabolic and mitochondrial pathways as linked with ATF4, 
but not with DDIT3/CHOP, befitting with the predominant role 
of ATF4 in mitochondrial homeostasis (Fig. 9 C). Importantly, 
OXP HOS correlated negatively with the expression of both 
ATF4 and CEB PB (Fig. 9 C). As expected, NCOR1, a well-
known mitochondrial repressor (Yamamoto et al., 2011), also 
showed a robust negative correlation with OXP HOS (Fig. 9 C), 
Figure 8. Mitochondrial stress activates the ATF4 pathway in vitro and in vivo independent of the UPRmt. (A) mRNA expression analysis of the ATF4 path-
way and UPRmt genes in HeLa cells 6 and 24 h after exposure to paraquat (PQ) at a final concentration of 400 µM. (B and C) Enrichment score plots from 
GSEA using RNA sequencing data of cells treated with (B) the TRAP1 inhibitor GTPP and (C) the LONP1 inhibitor CDDO (GSE75247). List of mitochondrial 
stress genes (mt-stress genes; Table S5) was used as the gene set of interest. FDR q-val, false discovery rate adjusted p-value; NES, normalized enrichment 
score. (D and E) mRNA expression analysis of the ATF4 pathway and UPRmt genes in HeLa cells after (D) knockdown of LONP1 using two different shRNAs 
and (E) 6 and 24 h of exposure to mdivi-1 at a final concentration of 50 µM. (F and G) Enrichment score plots from GSEA using microarray data (F) from 
hearts of mice deficient in ClpP (GSE40207) and (G) from brains of mice deficient in Htra2 (GSE13035). NOM p-val, nominal p-value. (H and I) Barcode 
plot representing the enrichment in the core mt-stress genes in (H) mitochondrial myopathies versus nonmitochondrial myopathies (GSE43698) and (I) my-
opathies caused by mtDNA deletions (GSE1462). Enrichment was analyzed using the fold-change relative to control. p-value was calculated using the ROA 
ST test, which confirmed that gene expression changes induced by mitochondrial stress significantly correlate with gene expression changes caused by mi-
tochondrial myopathies. Black vertical lines represent the genes, and the red and blue rectangles the cutoff for the up-regulated and down-regulated genes, 
respectively. The black horizontal line indicates neutral enrichment, whereas the red line shows the enrichment of up-regulated genes. All experiments 
were independently performed at least two times, using triplicates for each condition; data are presented as mean ± SEM of a representative experiment; 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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validating our experimental approach. These results indicate 
that the activation of the ATF4 pathway seems to oppose mi-
tochondrial function, in agreement with our previous results in 
cells upon ATF4 LOF or treatment with ISR IB (Figs. 6 H and 
7 D). Importantly, the fact that the relationship of ATF4 and 
mitochondrial function occurs in basal nonstressed conditions 
in vivo, in which the mt-stress genes showed a transcriptional 
coregulation, extends the ATF4 function from a pure stress re-
sponse to a role in homeostasis.
To deepen into this in vivo coregulation of ATF4 and its 
targets genes, we explored the expression of Atf4 in the BXD 
mouse genetic reference population. We mapped the Atf4 tran-
script levels to a trans–expression quantitative trait locus on 
chromosome 1 (170–180 Mb) in multiple mouse tissues, espe-
cially those related to the central nervous system (Fig. 9, D and 
E). Notably, several Atf4 target genes, including Asns and most 
of the cytosolic aaRS, also have a trans–expression quantitative 
trait locus in the same locus at chromosome 1 (Mozhui et al., 
2008), suggesting that this locus can control their expression 
through the regulation of Atf4 expression. By exploring the genes 
under this quantitative trait locus (QTL), we identified six genes 
(Copa, Atp1a4, Fh1, Adamts4, Usp21, and Olfr248) that contain 
Figure 9. Genetic link of ATF4 and mitochondrial stress in human and mouse populations. (A and B) Multitissue correlation network analysis of transcript 
levels across (A) 49 human tissues in GTEx and (B) 16 mouse tissues in the BXD genetic reference population. Nodes represent the transcripts and the 
width of the ties among nodes indicate the probability to show a significant positive correlation in all tissues analyzed. The human network shows a 
tighter clustering likely caused by the higher number of tissues and samples per tissues. (C) Heatmap representing the KEGG pathway analysis of the top 
negative-correlated genes across 49 tissues using GTEx data for ATF4, CEB PB, DDIT3/CHOP, and NCOR1 (used as positive control). Color key represents 
the negative logarithm base 10 of the p-value of each pathway obtained in the analysis. (D) Expression quantitative trait locus (eQTL) analysis of Atf4 
transcript level in the prefrontal cortex. The yellow mark represents the Atf4 gene locus on chromosome 15, whereas the red mark represent the position 
of a trans-eQTL for Atf4 expression levels on chromosome 1 (Chr1). (E) eQTL mapping of Atf4 transcript levels across several tissues identifies a common 
and strong trans-eQTL on chromosome 1 (170–180 Mb). (F) Representation of the chromosome 1 locus (170–180 Mb) containing 142 genes, 6 of which 
have nonsynonymous substitutions, and only one gene, Fh1, encodes a mitochondrial protein. Fh1 contains a nonsynonymous sequence variant (A296T; 
rs32536342) that segregates in the BXDs. This sequence variant regulates the expression levels of Fh1, which in turn regulates Atf4 expression. (G) mRNA 
expression analysis of HeLa cells after knockdown of fumarate hydratase (shFH) and treatment with monomethyl fumarate at 2.5 mM for 24 h. Data are 
presented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001. (H) Enrichment score plot from GSEA using microarray data from renal cysts of 
mice with renal tubule specific inactivation of Fh1 (Fh1−/−; GSE29988). The list of mitochondrial stress genes (mt-stress genes; Table S5) was used as the 
gene set of interest. FDR q-val: false discovery rate adjusted p-value; NES, normalized enrichment score; NOM p-val, nominal p-value. (I) Scheme summa-
rizing our working hypothesis. Mitochondrial stress stimulates the phosphorylation of the eIF2α, which inhibits cytosolic translation and activates the ATF4 
pathway. At the same time, mitochondrial stress also reduces the expression of MRPs to inhibit mitochondrial translation and protect mitochondrial function.
 o
n
 N
ovem
ber 15, 2017
jcb.rupress.org
D
ow
nloaded from
 
ATF4 regulates mitochondrial stress response • Quirós et al. 2039
nonsynonymous substitutions, including nonsense, splicing site, 
and frameshift mutations, which segregate in the BXDs. One of 
these genes, and the only mitochondrial protein, was fumarate 
hydratase 1 (Fh1; Fig. 9 F), a tricarboxylic acid cycle enzyme 
that catalyzes the reversible hydration/dehydration of fumarate 
to l-malate. In the BXD population, a missense variant in Fh1 
gene modulates its expression level in several tissues (Wang et 
al., 2016), whereas the LOF of the C.  elegans orthologue of 
Fh1, fum-1, activates the UPRmt in worms (Wang et al., 2016). 
In combination, these data suggest a conserved role of Fh1 in 
the mitochondrial stress response from C. elegans to mammals.
To validate Fh1 as a possible candidate gene regulating 
Atf4 expression, we hence knocked down FH expression and 
treated HeLa cells with fumarate, the FH substrate. Both LOF 
of FH and treatment with fumarate activated the ATF4 pathway 
in vitro (Fig. 9 G). Similarly, analysis of kidney microarray ex-
tracted from Fh1-deficient mice (Adam et al., 2011) also evi-
denced the activation of the ATF4 pathway, as illustrated by the 
GSEA enrichment plot of the mt-stress genes (Fig. 9 H). These 
results demonstrate that changes in the Fh1 expression levels 
activate Atf4 expression, which in turn would activate the ex-
pression of its targets genes, including Asns, the cytosolic aaRS 
and the rest of the mt-stress genes. Collectively, these results 
hence reveal that modulation of mitochondrial function in both 
basal and stress conditions regulates the expression of ATF4 
and its target genes in both human and mouse populations.
Altogether, our results demonstrate that the activation of 
ATF4 through the ISR is a general retrograde response that reg-
ulates both cellular metabolism and mitochondrial function to 
allow a global cellular adaptation to mitochondrial stress.
Discussion
By using a combined analysis of the transcriptome, proteome, 
and metabolome of HeLa cells exposed to four different mito-
chondrial stressors, we obtained a multilayered footprint/map 
of mitochondrial stress response pathways. By analyzing the 
common and global changes in our multiomics data, we iden-
tified that, despite the profound changes observed in the mi-
tochondrial proteome, the stress response is mainly performed 
by a network of genes/proteins and metabolites that regulates 
cytosolic translation and rewires cellular metabolism. The use 
of four different stressors has enabled us to discern specific re-
sponses obtained by the use of individual compounds or genetic 
interventions from the overall and common response that oc-
curs upon mitochondrial stress.
Despite some differences in response observed with each 
stressor, we identified that the general retrograde response is 
coordinated by ATF4, which acts downstream of the ISR. The 
activation of this response aims to decrease global translation, 
similarly to what is observed in a yeast model of mitochondrial 
stress (Wang and Chen, 2015), and enable the translation of 
specific cytoprotective genes. These results are in agreement 
with previous data that have shown the activation of the ISR 
under different mitochondrial stress conditions in mammals 
(Tyynismaa et al., 2010; Martínez-Reyes et al., 2012; Michel 
et al., 2015; Bao et al., 2016; Münch and Harper, 2016) and in 
worms (Baker et al., 2012). In addition to the mitonuclear re-
sponse regulated by ATF4, mitochondrial stress also triggers a 
decrease in MRP levels. It is of note that variation in the expres-
sion levels of the MRPs is both at the origin of a mitochondrial 
stress response that regulates lifespan (Houtkooper et al., 2013) 
as well as a key target of this feedback regulation to adapt mi-
tochondrial proteostasis. This makes the MRPs nodal points in 
mitonuclear stress communication pathways. Interestingly, the 
activation of the ISR can also couple the decrease in cytosolic 
protein translation with the attenuation of mitochondrial import 
(Rainbolt et al., 2013), which would collaborate in reducing mi-
tochondrial function under stress conditions.
Surprisingly, under the conditions used, we did not detect 
activation of the prototypical UPRmt, which is generally charac-
terized by the induction of the chaperones HSP60 and HSP10 
and the protease CLPP, among others, and which has been 
mainly described in invertebrates and cellular models as the 
primary transcriptional response to mitochondrial proteotoxic 
stress (Zhao et al., 2002; Haynes et al., 2007; Durieux et al., 
2011; Houtkooper et al., 2013). Some recent evidence might 
help to explain this apparent contradiction, such as the require-
ment of additional regulatory components, like epigenetic mod-
ifications or non–cell-autonomous factors (Durieux et al., 2011; 
Merkwirth et al., 2016; Tian et al., 2016), as well as particular 
specificities of given cells, tissues, or stressors to activate the 
UPRmt (Dogan et al., 2014; Münch and Harper, 2016).
Overall, our multiomics analysis enabled us to iden-
tify an ATF4-dependent mitochondrial stress signature that is 
shared between many mitochondrial stress conditions in cellu-
lar and animal models and that is characterized primarily by 
the activation of amino acid biosynthesis pathways. A similar 
response was also observed in mitochondrial myopathies in 
vivo, extending its relevance to human pathology. Perhaps most 
importantly, the observation of a tight coregulated network of 
mt-stress genes in different human (GTEx) and mouse (BXD) 
tissues under physiological conditions assigns a key role of 
ATF4 and its upstream mediator fumarate hydratase in the reg-
ulation of cellular metabolism in equilibrium in the absence of 
stress. ATF4 and its coregulated gene circuit could hence be 
important both to adapt mitochondrial and cellular function to 
genetic variation, metabolic activity, and environmental cues in 
homeostasis (health), as well as provide a mechanistic basis to 
explain mitochondrial dysfunction in stress and disease.
Conceptually, our work extends our understanding of mi-
tonuclear communication in stress and homeostasis in mammals. 
We demonstrate that ATF4 is a main player in the mitonuclear 
stress response, being activated by the ISR and controlling cy-
tosolic translation and homeostasis. This ATF4-driven response 
is coupled with an ATF4-independent local mitochondrial pro-
teostatic response, which attenuates mitochondrial translation by 
decreasing the levels of the MRPs (Fig. 9 I). The activation of 
these two events exemplifies the important role of mitonuclear 
communication to respond to stress, synchronizing nuclear and 
mitochondrial genomes by concurrently decreasing cytosolic 
and mitochondrial translation. We furthermore anticipate that 
our comprehensive approach to study mitochondrial stress in 
cells will provide a platform that will contribute to the discovery 
of essential new players in the pathogenesis of diseases linked 
with mitochondrial dysfunction.
Materials and methods
Cell lines and reagents
HeLa, 293T, and COS7 cells were obtained from ATCC. MEFs were sup-
plied by C. López-Otín (University of Oviedo, Oviedo, Spain). All cell 
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lines were cultured in DMEM plus l-glutamine and pyruvate with 10% 
inactivated FBS and penicillin and streptomycin (Thermo Fisher Scien-
tific) and maintained at 37°C and 5% CO2. Reagents were obtained from 
the following sources: doxycycline hyclate (D9891; Sigma-Aldrich), ac-
tinonin (A6671; Sigma-Aldrich), FCCP (C2920; Sigma-Aldrich), MB 
(10–1472-5; Tebu.bio), Rotenone (R8875; Sigma-Aldrich), antimycin 
A (A8674; Sigma-Aldrich), oligomycin (495455; EMD Millipore), tu-
nicamycin (T7765; Sigma-Aldrich), ISR IB (SML0843; Sigma-Aldrich), 
monomethyl fumarate (651419; Sigma-Aldrich), Mdivi-1 (M0199; 
Sigma-Aldrich), and paraquat dichloride hydrate (36541; Sigma-Aldrich). 
pCAG GS vectors containing WT (pCAG GS-OTC) and mutant (pCAG 
GS-ΔOTC) forms of ornithine-transcarbamylase were a gift from 
N. Hoogenraad (La Trobe University, Melbourne, Australia). Cells were 
treated during 6 h or 24 h with 30 µg/ml doxycycline, 50 µM actinonin, 
10 µM FCCP, or 50 µM MB. Induction of ER stress was performed by 
treating the cells with 2.5 µg/ml (6 h) or 1 µg/ml (24 h) tunicamycin. ISR 
IB was used at 500 nM, monomethyl fumarate at 2.5 mM, Mdivi-1 at 
50 µM, and paraquat at 400 µM.
RNA sequencing library preparation and analysis
Total RNA from HeLa cells was extracted using TRIzol (Thermo 
Fisher Scientific) and purified by column using RNeasy Mini kit 
(QIA GEN). 500 ng total RNA was enriched for poly(A) RNA, and 
then barcoded libraries for sequencing were prepared using the Lex-
ogen mRNA Sense kit for Ion Torrent according to manufacturer’s 
standard protocol. Libraries were amplified 13 cycles, and the quality 
of each library was checked on an Agilent Technologies Bioanalyzer 
DNA High Sensitivity chip. The libraries were pooled based on the 
concentration of each sample between 200 and 350 bp, purified on a 
Pippin Prep gel, quantified by the Agilent Technologies Bioanalyzer, 
and sequenced on an Ion Torrent Proton sequencer at 30x coverage 
depth. The reads obtained were first trimmed out to remove adaptor 
sequences and then mapped using a combined pipeline of TopHat2 
(Kim et al., 2013) and bowtie2 (Langmead and Salzberg, 2012) 
against the human genome (GRCh37). HTSeq-count (Anders et al., 
2015) was then used to obtain the counts of each gene. Differential ex-
pressed genes in each condition were identified using R/Bioconductor 
package edgeR (Robinson et al., 2010). The accession number for the 
RNA sequencing data reported in this paper is GEO GSE84631.
Proteomic analysis
HeLa cells treated with all described compounds were washed twice 
with ice-cold PBS and scraped in PBS. Cell pellets were lysed with 
urea buffer (8 M urea, 75 mM NaCl, 50 mM EPPS, pH 8.5, with added 
cOmplete protease inhibitors [Roche] and PhosSTOP phosphatase 
inhibitors [Roche]). Cell debris was spun down for 15 min at 13,000 g 
at 4°C.  Protein concentration was determined using the BCA assay 
(Thermo Fisher Scientific). 100 µg lysate was reduced with 5 mM 
TCEP for 30 min and then alkylated with 14 mM iodoacetamide for 30 
min in the dark, and all reactions were incubated at room temperature. 
Then, proteins were precipitated by methanol/chloroform precipitation 
and resuspended in 200  mM EPPS, pH 8.5.  Protein digestion was 
performed for 16 h at room temperature with LysC at a 1:100 (LysC/
protein) ratio. The day after, trypsin was added at a 1:75 (trypsin/
protein) ratio and incubated at 37°C for 5 h. Then, isobaric labeling of 
the peptides was performed using the 10-plex TMT reagents (Thermo 
Fisher Scientific). In brief, 100 µg peptides was labeled with 0.2 mg 
TMT reagent (previously dissolved in acetonitrile [ACN]), final 
concentration of ACN ∼30% (vol/vol), for 1 h at room temperature. 
Finally, the reactions were quenched for 15 min with hydroxylamine to 
a final concentration of 0.3% (vol/vol). The TMT-labeled peptides were 
combined equally and dried via vacuum centrifugation. Dried peptides 
were resuspended in 3% FA, 3% ACN, desalted using a Sep-Pak C18 
solid-phase extraction cartridge (Waters), and dried down again via 
vacuum centrifugation. The pooled TMT-labeled peptides were then 
subjected to a basic pH reversed-phase HPLC fractionation as described 
(Paulo et al., 2015) and fractionated into 24 fractions. Half of them were 
vacuum centrifuged to dryness, dissolved in 3% FA, 3% ACN, desalted 
via StageTip, dried again via vacuum centrifugation and resuspended in 
10 µl of 3% FA, 3% ACN for mass spectrometry analysis. All samples 
were run in an Orbitrap Fusion mass spectrometer (Thermo Fisher 
Scientific) coupled to a Proxeon EASY-nLC II LC pump (Thermo 
Fisher Scientific). Peptides were fractionated on a microcapillary 
column packed with GP-18 resin (1.8 µm, 200 Å; Sepax). Peptides were 
separated using a 135-min gradient of 6–26% ACN in 0.125% formic 
acid at a flow rate of ∼350 nl/min. Each analysis used the multinotch 
MS3-based TMT method (McAlister et al., 2014). For each FTMS1 
spectrum detected in the Orbitrap (resolution of 120k; mass range 
400–1,400 m/z; automatic gain control [AGC] target 5 × 105, maximum 
injection time of 100 ms), precursors for MS2/MS3 analysis were 
selected using the TopSpeed parameter of 2 s. MS2 analysis consisted 
of collision-induced dissociation (quadrupole ion-trap analysis; AGC 
8 × 103; normalized collision energy = 35; maximum injection time 
150 ms). To create TMT reporter ions, a synchronous-precursor-
selection MS3 scan was collected on the top 10 most intense ions in 
the MS2 spectrum. Synchronous-precursor-selection MS3 precursors 
were fragmented by high-energy collision–induced dissociation and 
analyzed in the Orbitrap (normalized collision energy = 55%, AGC = 
105, maximum injection time = 150 ms, and resolution = 60 K). The 
data analysis was performed with a SEQ UEST-based in-house software 
pipeline (Huttlin et al., 2010). In short, mass spectra were searched 
against the human Uniprot database (February 2014) and a reverse 
decoy database. A cysteine carbamidomethylation (+57.0215 D) and 
TMT tag (+229.1629 D) on lysine residues and peptide N termini were 
added as static modifications, and methionine oxidation (+15.9949 D) 
was set as a variable modification. Precursor ion tolerance was set at 20 
ppm and product ion tolerance at 0.9 D. Peptide-spectrum matches were 
adjusted to a 1% FDR using a linear discriminant analysis (Huttlin et al., 
2010), quantified by extracting the signal-to-noise ratio, and proteins 
were further collapsed to a final protein-level FDR of 1% (McAlister 
et al., 2014; Paulo et al., 2015). Differential expressed proteins were 
identified by fitting the data to a linear model and performing an 
empirical Bayes moderated t-statistics test, comparing each stress 
condition with control cells using the R/Bioconductor package limma 
(Ritchie et al., 2015). The mass spectrometry proteomics data have been 
deposited to the ProteomeXchange Consortium (http ://proteomecentral 
.proteomexchange .org) via the PRI DE partner repository with the 
dataset identifier PXD006293.
Metabolome analysis
Cells were seeded at density of 3 × 105 cells per well in six-well plates 
and treated the next day with selected drugs in quadruplicate. 24 h later, 
cells were washed twice with 75 mM ammonium carbonate buffer, pH 
7.4 (37°C), and cell metabolism was quenched by shock freezing of 
plates in liquid N2. Metabolites were extracted by adding ice-cold 
acetonitrile/methanol/water (40:40:20, vol/vol). The extraction proce-
dure was repeated twice. Scraped cells and supernatants were pooled 
in the same tube. To remove cell debris, tubes were centrifuged (4°C, 
13,000 rpm, 2 min), and the supernatants collected were assayed by 
flow injection analysis using time-of-flight mass spectrometry (6550 
QTOF; Agilent Technologies) operated in the negative ionization 
mode. High-resolution mass spectra were recorded from 50–1,000 m/z 
and analyzed as described previously (Fuhrer et al., 2011). Detected 
ions were putatively annotated by as searching matching metabolites 
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in the Kyoto Encyclopedia of Genes and Genomes (KEGG; Kanehisa 
et al., 2006) using an m/z tolerance of 0.001 and including all com-
mon electrospray derivatives. Differences between treatments and con-
trol cells were determined using the R/Bioconductor package limma 
(Ritchie et al., 2015).
Bioinformatics and statistical analysis
For RNA sequencing and quantitative proteomic analysis, Gene 
Ontology and KEGG pathway enrichment analysis were performed 
using goanna and kegga, respectively, from limma and edgeR packages. 
Pathways, genes and proteins selected in each condition were filtered 
after Benjamini-Hochberg correction at an adjusted P < 0.05 (FDR 5%). 
Network analysis of common down-regulated proteins was performed 
using STR ING (version 10.0; http ://string -db .org). De novo motif 
analysis was performed using HOM ER (http ://homer .salk .edu /homer) by 
selecting the common up-regulated genes in RNA sequencing analysis. 
Metabolic pathway analysis was performed using MetaboAnalyst 3.0 
(http ://www .metaboanalyst .ca; Xia et al., 2015) using a hypergeometric 
test for overrepresentation analysis and relative-betweenness centrality 
for pathway topology analysis. Correlation analysis was performed 
using the GTEx v6 dataset (http ://www .gtexportal .org) for human data 
and the datasets available in GeneNetwork (http ://www .genenetwork 
.org) for the BXD mouse genetic reference population. For GTEx data, 
reads per kilobase per million mapped reads (RPKM) of each transcript 
were filtered (selecting genes with more than 0.1 RPKM in at least 
10 individuals), log2 transformed, and quantile normalized across all 
samples for each tissue; only tissues with more than 30 individuals were 
used. Genes with a positive (Person’s rho > 0) or negative correlation 
(Pearson’s rho < 0) in each case and a significant correlation (P < 0.05) 
in each tissue were filtered. Common genes in 75% of the GTEx data 
(49 tissues) or BXD data (16 tissues) were selected for the analysis. 
Multitissue correlation networks were generated with Cytoscape (http ://
www .cytoscape .org), using edge width as an indication the percentage 
of tissues with positive correlation between genes (nodes). Enrichment 
analysis of top correlated genes was conducted using kegga function 
from the limma package. QTL analysis was performed using R/qtl 
package (Broman et al., 2003) selecting the following traits obtained 
from GeneNetwork: INIA Amygdala Cohort Affy MoGene 1 0 ST 
Mar11 RMA, UTH SC Mouse BXD Whole Brain RNA Sequence 
Nov12 RPKM Untrimmed, GE NIA AA Cerebellum mRNA M430v2 
May05 RMA, Hippocampus Consortium M430v2 Jun06 PDNN, VU 
BXD Midbrain Agilent Technologies SurePrint G3 Mouse GE May12 
Quantile, HQF BXD Neocortex ILM6v1 1 Dec10v2 RankInv, VCU 
BXD NAc Sal M430 2 0 Oct07 RMA, VCU BXD PFC Sal M430 2 0 
Dec06 RMA, and Full HEI Retina Illumina V6 2 Apr10 RankInv. All 
data analysis and plots were generated using R and RStudio (R Core 
Team and RStudio Team) and modified using Adobe Illustrator CC. 
For the rest of the analysis, data were expressed as mean ± SEM, and 
p-values were calculated using two-tailed Student’s t test for pairwise 
comparisons, one-way ANO VA for multiple comparisons, and two-way 
ANO VA for multiple comparisons involving two independent variables. 
Statistical tests were performed using RStudio and GraphPad Prism 6.0 
(*, P < 0.05; **, P < 0.01; ***, P < 0.001; n ≥ 3).
Seahorse analysis
The OCR and ECAR were measured using Seahorse XF96 equipment 
(Seahorse Bioscience Inc.) as previously described (Andreux et al., 
2014). In brief, cells were seeded at 10,000 cells per well and treated 
with different medium conditions or compounds for 24 h in 100 µl me-
dium. Before the measurements, plates were equilibrated in a CO2-free 
incubator at 37°C for 1 h. Analysis were performed using 1 µM oligo-
mycin, 10 µM FCCP, and 1 µM rotenone/antimycin as indicated. Data 
were normalized to protein levels. ATP-dependent respiration (or oli-
gomycin-sensitive respiration) was calculated as the difference in OCR 
before and after the addition of oligomycin.
Mitochondrial membrane potential and ROS measurements
Mitochondrial membrane potential (Δψm) was measured using the 
fluorescent tetramethylrhodamine methyl ester probe (Sigma-Aldrich), 
and ROS levels were measured using 2',7'-dichlorodihydrofluorescein 
diacetate (H2DCF DA; Abcam) and MitoSox (Thermo Fisher Scien-
tific). Cells were stained with selected probes and fluorescence was an-
alyzed using Gallios Flow Cytometer (Beckman Coulter). In brief, for 
tetramethylrhodamine methyl ester, cells were stained with 200 nM for 
15 min at 37°C, washed twice and resuspended in PBS. For H2DCF DA 
and MitoSox, cells were stained with 20 and 5 µM, respectively, and 
fluorescence was analyzed without washing.
26S proteasome assay
The in vitro assay of the 26S proteasome activity was performed as pre-
viously described (Vilchez et al., 2012) with minor changes. In brief, 
cells were lysed in proteasome activity assay buffer (50 mM Tris-HCl, 
pH 7.5, 250 mM sucrose, 5 mM MgCl2, 0.5 mM EDTA, 2 mM ATP, and 
1 mM DTT) by passing 10 times through a 29G syringe. Lysates were 
centrifuged at 10,000 g for 10 min at 4°C, and protein concentration 
of cell homogenates was determined by Lowry method. 10 µg total 
protein was incubated in proteasome activity assay buffer with 100 µM 
Suc-Leu-Leu-Val-Tyr-AMC (Bachem) to measure chymotrypsin-like 
proteasome activity. Peptide cleavage was monitored by measuring flu-
orescence (380 nm excitation, 460 nm emission) every 5 min for 1 h at 
room temperature on a VIC TOR X4 plate reader (PerkinElmer). Prote-
asome activity was determined by calculating the slope of the curves.
Quantitative RT-PCR
Total RNA from cells was extracted using TRIzol (Thermo Fisher Scien-
tific). 1–2 µg RNA was used for reverse transcription using the QuantiTect 
Reverse Transcription kit (QIA GEN). 10× diluted cDNA was used 
for quantitative RT-PCR reactions using the LightCycler 480 System 
(Roche) and a LightCycler 480 SYBR Green I Master Mix (Roche). All 
data were normalized to ACTB and GAP DH expression. Primer sets for 
quantitative real-time PCR analyses are shown in Table S1.
mtDNA levels
mtDNA levels were analyzed as previously described (Quiros et al., 
2017) using tRNA-Leu primers for mtDNA and POLG primers for 
nDNA. In brief, 10–50 ng total DNA extracted from cells was used for 
qPCR using the LightCycler 480 System (Roche) and a LightCycler 
480 SYBR Green I Master Mix (Roche). Relative mtDNA copy num-
ber was calculated by normalizing the amplification of tRNA-Leu 
(mtDNA) with the expression of POLG (nuclear DNA).
Immunoblot analysis
Cultured cells were washed with PBS and lysed in RIPA buffer contain-
ing 50 mM Tris buffer, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% 
SDS, 10 mM EDTA, with cOmplete protease inhibitors (Roche) and 
PhosSTOP phosphatase inhibitors (Roche). Once homogenized, lysed 
cells were sonicated and centrifuged at 13,000 g at 4°C for 15 min, and 
supernatants were collected. The protein concentration of the superna-
tant was evaluated using the Lowry technique. Equal protein amounts 
were boiled in Laemmli buffer and run in SDS-polyacrylamide. After 
electrophoresis, gels were electrotransferred onto polyvinylidene fluo-
ride membranes (EMD Millipore), blocked with 5% nonfat dried milk 
in TBS-T (TBS with 0.05% Tween-20), and incubated with primary 
antibodies following the commercial instructions. The following pri-
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mary antibodies were used: mouse anti–β-actin (sc-47778; Santa Cruz 
Biotechnology, Inc.); mouse anti-HSP90 (BD Biosciences, 610418); 
OXP HOS antibody cocktail (mouse mAbs, ab110413; Abcam); 
mouse anti-HSP60 (ADI-SPA-806; Enzo Life Sciences); mouse 
anti-CLPP (WH0008192M1-100; Sigma-Aldrich); mouse anti-HSPA9 
(ABIN361739; Antibodies online); rabbit anti-LONP1 (HPA002192; 
Sigma-Aldrich); rabbit anti-OTC (sc-102051; Santa Cruz Biotechnol-
ogy, Inc.); mouse anti-OPA1 (BD, 612606); rabbit anti-CREB-2 (ATF4, 
sc-200; Santa Cruz Biotechnology, Inc.); phospho-eIF2α (Ser51) rabbit 
mAb (9721; Cell Signaling Technology); eIF2α rabbit mAb (9722; Cell 
Signaling Technology); and α tubulin (T5168; Sigma-Aldrich). Sec-
ondary antibodies used were goat anti–rabbit HRP (AC2114; Azure 
Biosystems) and goat anti–mouse HRP secondary antibody (AC2115; 
Azure Biosystems). All primary antibodies were used at 1:1,000, and 
secondary antibodies were used at 1:10,000. Images were scanned on 
an Azure Imager c300 (Azure Biosystems).
Viral package and cell infection
Lentiviruses were produced by cotransfecting HEK293T cells 
with lentiviral and packaging (pCMV-dR8.2 dvpr) and envelope 
(pCMV-VSV-G) plasmids in a ratio of 4:3:1, respectively, using FUG 
ENE 6 (Promega) following the manufacturer’s instructions. The pack-
aging and envelope vectors were created by Robert Weinberg (White-
head Institute for Biomedical Research, Cambridge, MA) and obtained 
through Addgene (plasmids 8455 and 8454). Transfection medium 
was removed 24 h after transfection, and fresh medium was added to 
the plate. Cell supernatants were collected at 24 and 48 h and filtered 
through a 0.45-µm sterile filter. Cells were seeded in six-well plates at 
20–30% confluence 24 h before infection. The following day, 1 ml viral 
supernatant supplemented with 5 mg/ml polybrene (EMD Millipore) 
was added to growing cells. This step was repeated twice, and cells 
were left to recover for 24 h in growth media before 2 µg/ml puromy-
cin selection. pLKO.1 vector was used as a control. The shRNAs used 
are listed in Table S2.
CRI SPR-Cas9–mediated gene knockout
Gene knockout of ATF4 in HeLa cells was conducted via CRI SPR-
Cas-9–mediated genome editing as previously described (Sanjana 
et al., 2014). gRNAs against exon 1 of ATF4 were designed using 
Benchling (https ://benchling .com) and cloned into the Lenti CRI SPR 
v2 plasmid, a gift from F. Zhang (Broad Institute of MIT and Harvard, 
Cambridge, MA; (plasmid 52961; Addgene). Cells were infected in an 
analogous way as the previously described for shRNA and selected for 
48 h with 2 µg/ml puromycin. After selection, cells were single-cell 
sorted with a flow cytometer into 96-well plates. Clones were grown 
for 2 wk, and the resultant colonies were trypsinized and expanded. 
Gene knockout was confirmed by Sanger sequencing and Western blot 
analysis. The sgRNA sequence for ATF4 was 5′-TCT CTT AGA TGA 
TTA CCT GG-3′ (plus strand).
Online supplemental material
Fig. S1 shows RNA sequencing and proteomic analysis upon mito-
chondrial stress. Fig. S2 shows an extended data from the analysis 
of the commonly down-regulated proteins upon mitochondrial stress. 
Fig. S3 shows extended data from the analysis of the commonly up- 
regulated transcripts and proteins and from the metabolomics analysis. 
Fig. S4 shows the generation of ATF4 LOF cells and the exclusion of 
UPRer and UPRmt pathways upon mitochondrial stress. Table S1 shows 
a list of primer sets used for quantitative RT-PCR analyses. Table S2 
shows the list of shRNAs used. Tables S3 and S4 contain the normal-
ized RNA sequencing and proteomics data. Table S5 contains the list of 
the common differentially expressed genes and proteins in mitochon-
drial stress. Tables S6 and S7 contain gene enrichment analysis of each 
stressor in RNA sequencing and proteomics, respectively. Table S8 
contains nontargeted metabolomics raw data. 
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